What is the difference between acute and chronic inflammation?

Acute inflammation is a rapid, visible and time-limited protective response that initiates healing. Chronic inflammation proceeds at a low level, often without symptoms and over a long period. Because it is barely perceptible, it is called 'silent inflammation' and is linked to creeping tissue damage.

Can inflammaging be treated with peptides?

There is currently no robust basis for this. Substances such as BPC-157 show anti-inflammatory effects in animal experiments, but meaningful human studies are lacking, and they are not approved as human medicines. Statements that such peptides act 'against aging' or 'against inflammation' in humans are claims, not proven facts.

Is chronic inflammation dangerous?

Low-grade chronic inflammation is linked in research to a higher risk of age-associated diseases such as cardiovascular problems, metabolic disorders and neurodegeneration. However, an association is not the same as proof in an individual case. In case of suspicion or elevated inflammatory values, a medical evaluation is advisable, especially with hormonal and metabolic issues.

Inflammation7 min readLast reviewed: June 2026

Chronic Inflammation (Inflammaging): What Silent Inflammation Has to Do With Aging

Inflammation has a bad reputation, but it is first and foremost a vital protective mechanism: acute inflammation fights pathogens, clears away damaged tissue and initiates healing. It becomes a problem when this state no longer subsides but instead continues at a low level over the long term. This "silent" chronic inflammation is referred to in the context of aging as inflammaging and is linked to cardiovascular disease, metabolic disorders, neurodegeneration and frailty. Around so-called regeneration or healing peptides, there is hope that they could be used to specifically counter inflammation and aging. This article puts into perspective what is established, what remains hypothesis and where human evidence is lacking - without promises of a cure and without instructions for use.

Machine-assisted translation. The German original is the authoritative version.

Key points

Acute inflammation protects and heals; chronic, low-grade inflammation continues to smolder unnoticed and is considered relevant to health.
Inflammaging describes the age-related rise in silent inflammation, driven among other things by senescent cells and their SASP.
Chronic inflammation is linked to many age-associated diseases, but it is one contributing factor of aging, not its sole cause.
So-called healing peptides such as BPC-157 rely almost exclusively on animal data; robust human evidence and approval for use in humans are lacking.
BPC-157 is not approved as a human medicine and is on the WADA Prohibited List - advertising claims against inflammaging remain assertions.

Acute Versus Chronic Inflammation - an Important Distinction

Acute inflammation is a rapid, time-limited response by the immune system. It classically manifests as redness, warmth, swelling and pain, is clearly visible and subsides again after days to weeks. This process is meaningful and necessary, because it eliminates the cause and triggers repair.

Chronic inflammation, by contrast, proceeds differently. It is low-grade, often without any recognizable symptom and without an acute trigger such as an infection. Instead of subsiding, it continues to smolder over months or years. Precisely because it is barely noticeable, it is often referred to as 'silent inflammation'. In the blood and in tissues it can be detected through persistently slightly elevated inflammatory signals. This continuous burden is not regarded as harmless, but as a contributing cause of creeping tissue damage.

Acute: rapid, visible, time-limited, healing-promoting
Chronic: low-grade, often symptomless, long-lasting
Silent inflammation is usually not directly perceptible
What matters is not inflammation itself, but that it no longer subsides

Inflammaging: When Aging and Inflammation Drive Each Other

The term inflammaging (from the English 'inflammation' and 'aging') describes the observation that the level of inflammation rises systemically with age - even without a recognizable infection. Reviews classify this state as chronic, low-grade systemic inflammation associated with an increased disease burden and mortality in old age.

Proposed mechanisms include, among others, the accumulation of aged, so-called senescent cells. These cells no longer divide but also do not die off; instead they release a cocktail of pro-inflammatory messenger substances - in technical terms, the senescence-associated secretory phenotype (SASP). Added to this are factors such as mitochondrial dysfunction, declining cellular 'waste disposal' (autophagy) and changes in the gut flora. Important for understanding: research describes a reciprocal cycle here. The aging processes fuel the inflammation, and the inflammation in turn accelerates the aging processes.

Inflammaging = age-related rise in low-grade inflammation
Senescent cells and their SASP are considered central drivers
Further factors: mitochondria, autophagy, gut flora
Inflammation and aging reinforce each other reciprocally

Connection to Age-Related Diseases - What the Research Shows

The available data come predominantly from observational and basic research. Review articles link chronic inflammation to a broad spectrum of age-associated diseases, including cardiovascular disease, metabolic disorders, neurodegenerative diseases, kidney dysfunction and general frailty. Inflammatory markers in the blood are described in the literature as having predictive value for the development of such diseases across several organ systems.

To put it honestly: an association (correlation) is not the same as a proven cause-and-effect mechanism for every individual case. Inflammaging is a plausible and well-documented concept, but it is not a single 'switch' that one can simply flip. Inflammation is one of several interwoven factors of aging, not the sole cause.

Linked, among others, to cardiovascular, metabolic, brain, kidney and frailty issues
Inflammatory markers are considered risk indicators, not a single cause
Correlation is not the same as causation
Inflammaging is one part of aging, not the entire mechanism

Regeneration and 'Healing Peptides': Hope, Hype and an Evidence Gap

In forums and marketing, certain peptides are promoted as agents that are supposed to dampen inflammation and heal tissue faster. A frequently cited example is BPC-157, to which anti-inflammatory and tissue-healing effects are attributed in animal experiments. This is precisely where caution is warranted: a recent literature and patent review notes that practically all data come from small-animal models (rats, mice) and that meaningful human studies are lacking. A phase I study begun in 2015 was discontinued in 2016 without published results.

The regulatory status is likewise clear and should be stated honestly: BPC-157 is not approved by any medicines authority for use in humans. The US Anti-Doping Agency classifies it as an experimental, unapproved substance that, since 2022, has been on the WADA Prohibited List in category S0 (non-approved substances); accordingly, there is no known safe dosage in humans. Other substances mentioned in this context, such as TB-500 or the fragment KPV, are at a similarly early stage in terms of evidence. What looks promising in animal models is therefore explicitly not yet a proven benefit or evidence of safety in humans. The claim that such peptides act 'against inflammaging' remains for now a claim made by the community, not an established fact.

Effects rest overwhelmingly on animal experiments, hardly on human data
BPC-157: not approved anywhere as a human medicine, on the WADA Prohibited List (S0)
No known safe use in humans documented
Advertising promises 'against inflammation/aging' are claims, not proven statements

Realistic Assessment Instead of Quick Fixes

Inflammaging is a serious, scientifically well-described concept - but not a problem that can be 'solved' with a single substance. In research, lifestyle factors are considered the best-studied levers that are associated with lower inflammatory values; these include exercise, nutrition, sleep and managing stress. These are mentioned here only for context and are not an instruction.

Anyone who suspects chronic inflammation or wants to have markers such as elevated inflammatory values investigated should do so medically - especially when hormonal or metabolic issues play a role. Peptides from the grey market replace neither a diagnosis nor a tested therapy and bring their own, often unknown, risks.

There is no single 'anti-inflammation switch'
Lifestyle is the best-studied area of influence (mentioned only for context)
Elevated inflammatory values should be investigated medically
For hormonal and metabolic questions, medical supervision is important

Related substance profiles

BPC-157

Synthetic peptide — predominantly animal data, NOT approved for humans.

TB-500 / Thymosin β4

Actin-binding peptide — research substance, NOT approved.

KPV

An anti-inflammatory tripeptide from the α-MSH terminus — gut and research focus, not approved.

Frequently asked questions

What is the difference between acute and chronic inflammation?: Acute inflammation is a rapid, visible and time-limited protective response that initiates healing. Chronic inflammation proceeds at a low level, often without symptoms and over a long period. Because it is barely perceptible, it is called 'silent inflammation' and is linked to creeping tissue damage.
Can inflammaging be treated with peptides?: There is currently no robust basis for this. Substances such as BPC-157 show anti-inflammatory effects in animal experiments, but meaningful human studies are lacking, and they are not approved as human medicines. Statements that such peptides act 'against aging' or 'against inflammation' in humans are claims, not proven facts.
Is chronic inflammation dangerous?: Low-grade chronic inflammation is linked in research to a higher risk of age-associated diseases such as cardiovascular problems, metabolic disorders and neurodegeneration. However, an association is not the same as proof in an individual case. In case of suspicion or elevated inflammatory values, a medical evaluation is advisable, especially with hormonal and metabolic issues.

Sources

This article is for information and education only. It does not replace medical advice and deliberately contains no dosing, usage or sourcing information.

← All guide articles